Equities research analysts at StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “hold” rating on the biotechnology company’s stock. Pulmatrix Price Performance PULM stock opened at $1.89 on Thursday. Pulmatrix has a 12 month low of $1.55 and a […]